相关实验视频

Updated: Jun 12, 2025

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

In Vitro Model of Human Cutaneous Hypertrophic Scarring using Macromolecular Crowding

Published on: May 1, 2020

来自脂肪系干细胞的外体miR-194通过向TGF-β1阻碍了过度缩的痕形成

Zhishan Xu¹, Yuan Tian¹, Lijun Hao¹

¹The Plastic and Cosmetic Center, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, P.R. China.

Molecular medicine reports

|September 27, 2024

概括

脂肪基衍生干细胞外体 (ADSCs-Exos) 通过调节microRNA-194 (miR-194) 来减少缩性痕具有前景. 这种干预措施针对TGF-β1,减少纤维化和炎症,改善伤口愈合.

科学领域:

再生医学是一种再生医学.
皮肤病学皮肤病学
分子生物学分子生物学

背景情况:

过度缩性痕是由于异常的伤口愈合而产生的,其特点是过度纤维化和无组织的原沉积.
目前对缩性痕的治疗方法是有限的,原因是对其潜在的病理生物学的不完全理解.
外体非编码RNA正在成为减轻痕的潜在治疗剂.

研究的目的:

研究由脂肪基干细胞 (ADSCs-Exos) 衍生出来的外体细胞在减轻缩性痕形成方面的治疗潜力.
阐明特定非编码RNAs,特别是microRNA-194 (miR-194) 在ADSCs-Exos中介痕减少中的作用.
评估ADSCs-Exos治疗对高缩性痕模型中的关键纤维和炎症标志物的影响.

主要方法:

利用子耳朵模型诱导和研究过度缩的痕形成.
采用组织学技术 (H&E,马森三色) 和免疫组织化学用于痕评估.
进行了全面的分子分析,包括非编码RNA分析,途径丰富,蛋白质-蛋白质相互作用和miRNA-mRNA相互作用研究. 通过使用双露西法酶测定,RT-qPCR和免疫阻塞验证了验证的关键发现.

主要成果:

ADSCs-Exos治疗显著改变了长非编码RNA和miRNA的表达特征,对循环RNA的影响最小.
确定miR-194是关键调节剂,抑制TGF-β1促进体活性和表达,从而减少纤维化.
用ADSCs-Exos治疗导致促炎性细胞因子 (IL-1β,TNF-α) 的水平降低,并且改善了痕特征.

结论:

ADSCs-Exos,特别是通过对miR-194的调节,代表了管理缩性痕的有前途的治疗策略.
该机制涉及抑制TGF-β1信号,导致纤维化和炎症减少.
这项研究支持ADSCs-Exos的有针对性的应用,用于控制增殖性痕和改善伤口愈合结果.

关键词:

脂肪衍生干细胞的基因细胞.外基因组是外基因组的组成部分.过度缩的痕过度缩的痕微型RNA 194 微型RNA 194 在转化生长因子β1的转化生长因子β1

更多相关视频

Immunomagnetic Separation of Fat Depot-specific Sca1high Adipose-derived Stem Cells ASCs

Immunomagnetic Separation of Fat Depot-specific Sca1high Adipose-derived Stem Cells ASCs

Published on: August 11, 2016

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...